Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis
NCT ID: NCT01799824
Last Updated: 2013-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
52 participants
INTERVENTIONAL
2013-02-28
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
ANT-1403
ANT-1403
Vehicle
Vehicle
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANT-1403
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of moderate to severe primary axillary hyperhidrosis
* ≥50 mg of sweat production/axilla in 5 minutes as measured gravimetrically
* HDSS score of ≥3
Exclusion Criteria
* skin affliction in the axilla requiring medical treatment
* 20% aluminum hydrochloride, e.g. Drysol®, in 2 weeks prior of Baseline
* oral anticholinergic treatment
* botulinum toxin treatment in the prior 9 months
* history of surgery for axillary hyperhidrosis
* present or history of neuromuscular disease
* female subjects who are pregnant or are nursing a child
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anterios Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miami, Florida, United States
Pinellas Park, Florida, United States
West Palm Beach, Florida, United States
Louisville, Kentucky, United States
East Windsor, New Jersey, United States
Rochester, New York, United States
Raleigh, North Carolina, United States
Yardley, Pennsylvania, United States
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANT-1403-HHID-202
Identifier Type: -
Identifier Source: org_study_id